Complete Growth Overview on Generic Injectables Industry

Complete Growth Overview on Generic Injectables Industry

Hospira was a global American pharmaceutical and medical device company headquartered in Lake Forest, Illinois. It had approximately 19,000 employees. Prior to its acquisition by Pfizer, Hospira was the world's largest producer of generic injectable pharmaceuticals, manufacturing generic acute care and oncology injectables, as well as integrated infusion therapy and drug management systems. Hospira products are used by hospitals and alternative site providers, such as clinics, home care providers and long-term care facilities. It was formerly the hospital products division of Abbott Laboratories. On September 3, 2015, Hospira was acquired by Pfizer, which subsequently sold the medical device portion of Hospira to ICU Medical.

Get Sample PDF

Some of the key players of Generic Injectables Industry:

Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma, Endo International PLC

In January 2004, Abbott announced the split of its hospital products division. Hospira's name was chosen by employee vote. The name is derived from the words hospital, spirit, inspire and the Latin word "spero", which means "hope". Hospira became an independent company on May 3, 2004, with 14,000 employees, 14 manufacturing sites and estimated annual sales of $ 2.5 billion.

In 2007, Hospira purchased Mayne Pharma Ltd., an Australian specialty injectable pharmaceutical company, for $ 2.1 billion. In 2009, Hospira acquired the biotechnology businesses of Pliva-Croatia, the injectable generic pharmaceutical business of Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceutical company, for approximately $ 400 million, and TheraDoc, a clinical informatics company that develops hospital monitoring systems, in 2009. In 2010, Hospira acquired Javelin Pharmaceuticals, Inc., maker of the postoperative pain management drug Dyloject, for approximately $ 145 million.

Comments

Post a Comment

Popular posts from this blog

Latest Innovation Knocking-in Luxuries Industry

Image
Latest Innovation Knocking-in Luxuries Industry In economics, a luxury good (or luxury good) is a good whose demand increases more than proportionally as income increases, so that expenditures on the good become a larger proportion of total expenditure. Luxury goods contrast with basic necessities, where demand increases proportionally less than income. Luxury items are often used synonymously with superior items. Get Sample PDF Some of the key players of Luxuries Industry : LVMH, Ralph Lauren, Estee Lauder, Luxottica, Kering, Richemont, Ralph Lauren, L’Oreal, PVH, Swatch Group, Tapestry, Shiseido Group, Tiffany, Chow Tai Fook Jewellery Group, Lao Feng Xiang, Rolex, Prada Group, Michael Kors Holdings, Hermes, Burberry Group, Puig, Titan, Coty, Armani, Christian Dior, Hugo Boss, Onward Holdings, Fossil Group, Pandora, Swarovski Group The word "luxury" originated from the Latin word luxus, which means indulgence of the senses, regardless of cost. A luxury good can be identified...
Read more

Urgent Care Centers Market

Image
Exclusive Research Report on Urgent Care Centers Market by 2026 Emergency care is a category of walk-in clinics in the United States that focuses on providing outpatient care in a specialized medical facility outside of a traditional emergency room (emergency room). Emergency centers primarily treat injuries or illnesses that require immediate treatment but are not severe enough to require an emergency room (ED) visit. Urgent care centers differ from similar outpatient health centers such as emergency rooms and practical care clinics in the extent of the illnesses treated and the facilities available on site. Request for Sample Copy of this report Some of the key players of Urgent Care Centers Market : Concentra, Dignity Health care, MedExpress Urgent Care, CareSpot, Aurora Urgent Care, U.S. HealthWorks, Patient First, American Family Care, TexasMedClinic, Physicians Immediate Care The first emergency centers opened in the US in the 1970s. Since then, that health sector has expanded ...
Read more

Future Scope for Deep Sea Exploration Robot Industry

Image
 Future Scope for Deep Sea Exploration Robot Industry Deep-sea exploration is the study of physical, chemical, and biological conditions on the seabed for scientific or commercial purposes. Deep-sea exploration is considered a relatively young human activity compared to other areas of geophysical research, as the depths of the sea have only been explored in recent years. The ocean depths still remain a largely unexplored part of the planet, forming a relatively undiscovered domain. Get Sample PDF Some of the key players of Deep Sea Exploration Robot Industry : Atlas Maridan ApS, Forum Energy Technologies, Inc, Kongsberg Maritime Ltd, Oceaneering International, Inc, Subsea 7, Boston Engineering Corporation, C-Innovation, LLC, Deep Ocean Engineering Inc, General Dynamics Mission Systems, Inc, DOF Subsea AS In general, it can be said that modern deep-sea scientific exploration began when the French scientist Pierre Simon de Laplace studied the average depth of the Atlantic Ocean by o...
Read more